Tyropanoic Acid
Tyropanoic acid is an iodinated radiocontrast medium used for oral cholecystography to visualize the gallbladder and biliary tract by concentrating iodine in bile after hepatic uptake. It acts as a thyroid hormone synthesis inhibitor by blocking the conversion of T4 to T3, and was investigated for short-term management of thyrotoxicosis. Its radiographic and antithyroid properties made it useful in both diagnostic imaging and emergency thyroid management.
Molekularmasse
641,0200 g/mol
LogP
4,60
TPSA
66,40 Ų
Lipinski-Regel der Fünf
Bestanden
Wirkmechanismus
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
2D-Struktur
Cite this structure
Embed this structure
SMILES
CCCC(=O)Nc1c(I)cc(I)c(CC(CC)C(=O)O)c1I
InChI
InChI=1S/C15H18I3NO3/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22/h7-8H,3-6H2,1-2H3,(H,19,20)(H,21,22)
Molecular Formula
C15H18I3NO3
HBD / HBA
2 / 3
Rotierbare Bindungen
7
Schwere Atome
22
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
Tyropanoic acid is an iodinated radiocontrast medium used for oral cholecystography to visualize the gallbladder and biliary tract by concentrating iodine in bile after hepatic uptake. It acts as a thyroid hormone synthesis inhibitor by blocking the conversion of T4 to T3, and was investigated for short-term management of thyrotoxicosis. Its radiographic and antithyroid properties made it useful in both diagnostic imaging and emergency thyroid management.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Tyropanoic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201261. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5611. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tyropanoic-acid"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tyropanoic-acid/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tyropanoic-acid/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tyropanoic-acid/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tyropanoic-acid"></drugfyi-drug>